Skip to Main Content

Advertisement

Skip Nav Destination

Patritumab Deruxtecan: Paving the Way for EGFR-TKI–Resistant NSCLC

Cancer Discov (2022) 12 (1): 16–19.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Rima Hajjo
  • Dima A. Sabbah
  • Sanaa K. Bardaweel
  • Haizhen A. Zhong
Expert Opinion on Therapeutic Patents (2024) 34 (1-2): 51.
  • Qiuqiang Chen
  • Gang Jia
  • Xilin Zhang
  • Wenxue Ma
Frontiers in Immunology (2024) 14
  • Margaret E. Larsen
  • Hui Lyu
  • Bolin Liu
Chinese Medical Journal Pulmonary and Critical Care Medicine (2023) 1 (1): 11.
  • Sachie Hirai
  • Masashi Idogawa
  • Toshiyuki Sumi
  • Miki Yamaguchi
  • Toshiro Niki
  • Yuji Sakuma
Biochemical and Biophysical Research Communications (2022) 630: 24.
  • Nicolas Girard
  • Clémence Basse
Expert Review of Anticancer Therapy (2022) 22 (10): 1115.
  • Nicolas Girard
Current Treatment Options in Oncology (2022) 23 (11): 1626.
  • Lucía Gandullo-Sánchez
  • Alberto Ocaña
  • Atanasio Pandiella
Journal of Experimental & Clinical Cancer Research (2022) 41 (1)
Close Modal

or Create an Account

Close Modal
Close Modal